[go: up one dir, main page]

WO1999057246A8 - Animal cell culture media comprising non-animal or plant-derived nutrients - Google Patents

Animal cell culture media comprising non-animal or plant-derived nutrients

Info

Publication number
WO1999057246A8
WO1999057246A8 PCT/US1999/009574 US9909574W WO9957246A8 WO 1999057246 A8 WO1999057246 A8 WO 1999057246A8 US 9909574 W US9909574 W US 9909574W WO 9957246 A8 WO9957246 A8 WO 9957246A8
Authority
WO
WIPO (PCT)
Prior art keywords
animal
cell culture
plant
culture media
media
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1999/009574
Other languages
French (fr)
Other versions
WO1999057246A9 (en
WO1999057246A1 (en
Inventor
Paul J Price
Steve Gorfien
Douglas Danner
Mark Plavsic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Life Technologies Inc
Original Assignee
Life Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Life Technologies Inc filed Critical Life Technologies Inc
Publication of WO1999057246A1 publication Critical patent/WO1999057246A1/en
Publication of WO1999057246A8 publication Critical patent/WO1999057246A8/en
Anticipated expiration legal-status Critical
Publication of WO1999057246A9 publication Critical patent/WO1999057246A9/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/0043—Medium free of human- or animal-derived components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/36—Lipids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/40—Nucleotides, nucleosides or bases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/74—Undefined extracts from fungi, e.g. yeasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/76—Undefined extracts from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The present invention provides serum-free cell culture media formulations which are capable of supporting the in vitro cultivation of animal cells. The media comprise at least one nutrient of non-animal derivation, such as at least one plant peptide and/or at least one non-animal or plant lipid and/or fatty acid. The media may further optionally comprise an enzymatic digest or extract of yeast cells. The present invention also provides methods of cultivating animal cells in vitro using these cell culture media formulations. In addition, the media of the present invention can be used for growth of animal cells for virus production.
PCT/US1999/009574 1998-05-01 1999-05-03 Animal cell culture media comprising non-animal or plant-derived nutrients Ceased WO1999057246A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US7080798A 1998-05-01 1998-05-01
US09/070,807 1998-05-01
US30295399A 1999-04-30 1999-04-30
US09/302,953 1999-04-30

Publications (3)

Publication Number Publication Date
WO1999057246A1 WO1999057246A1 (en) 1999-11-11
WO1999057246A8 true WO1999057246A8 (en) 2000-10-12
WO1999057246A9 WO1999057246A9 (en) 2001-06-21

Family

ID=26751514

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/009574 Ceased WO1999057246A1 (en) 1998-05-01 1999-05-03 Animal cell culture media comprising non-animal or plant-derived nutrients

Country Status (1)

Country Link
WO (1) WO1999057246A1 (en)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6475725B1 (en) 1997-06-20 2002-11-05 Baxter Aktiengesellschaft Recombinant cell clones having increased stability and methods of making and using the same
AT409379B (en) 1999-06-02 2002-07-25 Baxter Ag MEDIUM FOR PROTEIN- AND SERUM-FREE CELL CULTURE
WO2001066560A2 (en) * 2000-03-07 2001-09-13 Forbes Medi-Tech Inc. Novel derivatives comprising phytosterols and/or phytostanols and alpha-lipoic and use thereof in treating or preventing cardiovascular disease, its underlying conditions and other disorders
EP1181865A1 (en) * 2000-08-23 2002-02-27 Universite Catholique De Louvain Cryoprotective solutions
PT2287288E (en) 2002-07-09 2012-12-10 Baxter Int Animal protein free media for cultivation of cells
GB0304799D0 (en) * 2003-03-03 2003-04-09 Glaxosmithkline Biolog Sa Novel method
US20060094104A1 (en) 2004-10-29 2006-05-04 Leopold Grillberger Animal protein-free media for cultivation of cells
FR2879214A1 (en) * 2004-12-14 2006-06-16 Pierre Fabre Medicament Sa PEPTIDE FRACTIONS PROMOTING THE GROWTH AND SYNTHESIS OF PRODUCT (S) OF INTEREST IN CELL CULTURE AND / OR TISSUE
NL1029059C2 (en) * 2005-05-17 2006-11-20 Noord Nl Oliemolen Holding B V Peptide preparation for growing and / or growing microorganisms and / or cells.
DE102005054577A1 (en) * 2005-11-16 2007-05-24 Cognis Ip Management Gmbh Use of esters of unsaturated, physiologically active fatty acids as nutrient media for cell cultures
ES2474573T3 (en) 2006-01-04 2014-07-09 Baxter International Inc Cell culture medium without oligopeptides
US8911964B2 (en) 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
EP2500413A1 (en) 2006-09-13 2012-09-19 Abbott Laboratories Cell culture improvements
EP2500416A1 (en) * 2006-09-13 2012-09-19 Abbott Laboratories Cell culture improvements
EP2702077A2 (en) 2011-04-27 2014-03-05 AbbVie Inc. Methods for controlling the galactosylation profile of recombinantly-expressed proteins
WO2013158273A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Methods to modulate c-terminal lysine variant distribution
WO2013158279A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Protein purification methods to reduce acidic species
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
WO2013176754A1 (en) 2012-05-24 2013-11-28 Abbvie Inc. Novel purification of antibodies using hydrophobic interaction chromatography
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
BR112015004467A2 (en) 2012-09-02 2017-03-21 Abbvie Inc method for controlling protein heterogeneity
CA2905010A1 (en) 2013-03-12 2014-09-18 Abbvie Inc. Human antibodies that bind human tnf-alpha and methods of preparing the same
WO2014151878A2 (en) 2013-03-14 2014-09-25 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
US8921526B2 (en) 2013-03-14 2014-12-30 Abbvie, Inc. Mutated anti-TNFα antibodies and methods of their use
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
US9598667B2 (en) 2013-10-04 2017-03-21 Abbvie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
US8946395B1 (en) 2013-10-18 2015-02-03 Abbvie Inc. Purification of proteins using hydrophobic interaction chromatography
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US20150139988A1 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
US12349704B2 (en) 2018-11-15 2025-07-08 Aleph Farms Ltd. High quality cultured meat, compositions and methods for producing same
CA3123504A1 (en) 2018-12-21 2020-06-25 Intervet International B.V. Serum free intracellular pathogen vaccine
CN113227354A (en) * 2019-01-17 2021-08-06 勃林格殷格翰动物保健美国公司 Serum-free culture medium for poultry vaccine production and application thereof
CN110257325A (en) * 2019-05-31 2019-09-20 苏州智享众创孵化管理有限公司 A method of the in vitro culture self-healing cell based on aloe extract
WO2021123099A1 (en) 2019-12-20 2021-06-24 Intervet International B.V. Reassorted isa virus
IL322673A (en) 2019-12-31 2025-10-01 Air Protein Inc High protein food compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9022545D0 (en) * 1990-10-17 1990-11-28 Wellcome Found Culture medium
WO1993024616A1 (en) * 1992-06-04 1993-12-09 Merck & Co., Inc. Process for attenuated varicella zoster virus vaccine production

Also Published As

Publication number Publication date
WO1999057246A9 (en) 2001-06-21
WO1999057246A1 (en) 1999-11-11

Similar Documents

Publication Publication Date Title
WO1999057246A8 (en) Animal cell culture media comprising non-animal or plant-derived nutrients
AU4751697A (en) Animal cell culture media comprising plant-derived nutrients
WO2002036735A3 (en) Dry powder cells and cell culture reagents and methods of production thereof
EP0945515A3 (en) Production of proteins using homologous recombination
MXPA05009096A (en) Animal-free cell culture method.
ATE507283T1 (en) DRY CELLS AND CELL CULTURE REAGENTS AND METHOD FOR THE PRODUCTION THEREOF
AU7545298A (en) Culture medium with yeast or soy bean extract as aminoacid source and no proteincomplexes of animal origin
GB2432846A (en) Medium and culture of embryonic stem cells
IL210618A (en) Cell cultures comprising isolated expanded human non-embryonic non-germ cells, pharmaceutical compositions comprising the same, methods for their preparation and methods for identifying modulators and differentiation factors
DE69939947D1 (en) METHOD OF PREPARING POLYPEPTIDES IN MUTATED ASPERGILLUS CELLS
WO2001051616A3 (en) Techniques for growth and differentiation of human pluripotent stem cells
WO2001081549A3 (en) Hepatocyte lineage cells derived from pluripotent stem cells
ATE331731T1 (en) METHOD FOR PRODUCING DIPHTHERIA TOXIN
AU2002336930A1 (en) Method for producing isolated cell cultures, culture medium for cultivating cell cultures and cell culture
EP2283721A3 (en) Genetically engineered duckweed
AU2003252396A1 (en) APPARATUS FOR ENVIRONMENT OF CULTIVATING/CULTURING PLANT, CULTIVATION/CULTURE METHOD and CULTIVATION/CULTURE APPARATUS
WO2000056905A3 (en) Method for enhancing and/or improving plant growth and/or yield or modifying plant architecture
WO2003048313A3 (en) Cell culture media
WO2000043499A3 (en) ANTI-TRANSFORMING GROWTH FACTOR BETA (TGF-β) TREATED STEM CELL COMPOSITION AND METHOD
CN109196091A (en) Generate the recombinant microorganism of biosurfactant
WO2008073348A3 (en) Microgravity bioreactor systems for production of bioactive compounds and biological macromolecules
BR0014671A (en) Method for the production of proteinaceous substances
AU4751797A (en) Defined systems for epithelial cell culture and use thereof
WO2005065341A3 (en) Dry powder cells and cell culture reagents and methods of production thereof
AU2001278700A1 (en) Method of culturing human chondrocytes

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): JP

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: C1

Designated state(s): JP

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: PAT. BUL. 45/99 UNDER (30) REPLACE "NOT FURNISHED" BY "09/302953"

AK Designated states

Kind code of ref document: C2

Designated state(s): JP

AL Designated countries for regional patents

Kind code of ref document: C2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

COP Corrected version of pamphlet

Free format text: PAGES 1-41, DESCRIPTION, REPLACED BY NEW PAGES 1-43; PAGES 42-45, CLAIMS, REPLACED BY NEW PAGES 44-48; PAGES 1/3-3/3, DRAWINGS, REPLACED BY NEW PAGES 1/3-3/3; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE

122 Ep: pct application non-entry in european phase